Development of expeditious RP-HPLC method for simultaneous estimation of bilastine and montelukast in fixed dosage combination

Authors

  • Revathi Boddu Malla Reddy Institute of Pharmaceutical Sciences (Malla Reddy Vishwavidyapeeth), Maisammaguda, Dhulapally, Secunderabad, Telangana, India-500014
  • Jithendar Reddy Mandhadi Faculty of Pharmaceutical Science, Assam down town University, Gandhinagar, Panikhaiti, Guwahati, Assam, India-781026
  • Narender Boggula Omega College of Pharmacy, Edulabad, Ghatkesar, Hyderabad, Telangana, India - 501 301.
  • Rajeshwar Vodeti School of Pharmacy, Anurag University, Venkatapur, Ghatkesar, Hyderabad, Telangana, India-500088.
  • Suchitra Duddagi Vision College of Pharmaceutical Sciences and Research, RNS Colony, Boduppal, Hyderabad, Telangana, India - 500 092.

DOI:

https://doi.org/10.69857/joapr.v13i6.1447

Keywords:

Montelukast, bilastine, validation, isocratic elution, specificity

Abstract

Background: Bilastine and montelukast are used to treat allergic rhinitis and chronic urticaria. Due to the recent increase in highly allergic disorders, demand for this combination has risen. Therefore, for regular quality control analysis, a new, rapid, and cost-effective method has become crucial. Compared with the previously reported methods, the present method is ultra-fast, with well-separated peaks within ̴ 3.0min and a total run time of 8 min. Because it uses a methanol-buffer system, it is less expensive, more environmentally friendly, and safer than an acetonitrile-based method.  This study presents a rapid, specific, and economical “reversed-phase high-performance liquid chromatography (RP-HPLC)” method for the simultaneous estimation of Bilastine and Montelukast. Methodology: The chromatographic conditions for the separation of drugs are achieved by leveraging a tailored composition of mobile phase with methanol and acidic phosphate buffer with a volume ratio of 55:45v/v, the “Zorbax C18 column (4.6×150mm, 5µ)” maintained at 35ºC with an optimized flow rate of 1.0 mL/min and detected at a wavelength of 260 nm. The injection volume is 10 µL, and the run time is 8 min. Results and Discussion: The retention times for the drugs bilastine and montelukast are 2.061 and 2.462 min, respectively. Linearity is observed with correlation coefficients of 0.9993 and 0.9994, respectively, for montelukast and bilastine at 1-5 µg/mL and 100-500 µg/mL. Efficient separation and quantification of these two therapeutically important compounds were achieved in this method. Conclusion: The developed analytical method has been validated in accordance with International Conference on Harmonisation (ICH) guidelines, demonstrating satisfactory performance with respect to specificity, accuracy, precision, linearity, and robustness. This novel RP-HPLC approach provides a valuable tool for pharmaceutical analysis and quality control.

Downloads

Download data is not yet available.

References

Sameera BM, Vasudha D, Srinivasa RY, Vara Prasad RK. RP-HPLC Method for Quantification of Bilastine and Monteleukast Sodium in Pharmaceutical Dosage form. Research J. Pharm. and Tech., 16(3), 1079-1084 (2023) https://doi.org/10.52711/0974-360X.2023.00180

Raajeswari S, Ajitha M. Stability indicating RP-HPLC Method Development and Validation for the simultaneous estimation of Montelukast and Bilastine in Bulk and Pharmaceutical Tablet Dosage form. World J Pharm Sci., 10(1), 90-97 (2022) https://doi.org/10.54037/WJPS.2022.100109

Vijayalakshmi K, Samuel AAB, Nageshwar RB. Quantification of Bilastine and Montelukast combination in formulations utilizing liquid chromatography: Stability studies. Int J App Pharm., 13(6), 210-215 (2021) https://doi.org/10.22159/ijap.2021v13i6.41915

Pranav V, Vivek ST, Deepak B, Balakrishna D. Development and Validation of RP-HPLC based Analytical method for the simultaneous estimation of Bilastine and Montelukast sodium in tablet dosage form. Current Research in Pharmaceutical Sciences., 12(1), 68-73 (2022) https://doi.org/10.24092/CRPS.2022.120110

Pachauri AD, Sonali BM, Prashant GD, Atul SS, Trupti DC et al. RP-HPLC method development and validation for the simultaneous estimation of Bilastine and Montelukast sodium in tablet dosage form. Afr J Biomed Res., 27(3), 302-309 (2024) https://doi.org/10.53555/AJBR.v27i3.1361

Seshadri RK, Desai MM, Raghavaraju TV, Krishnan D, Rao DV, Chakravarthy IE. Simultaneous Quantitative Determination of Metoprolol, Atorvastatin and Ramipril in Capsules by a Validated Stability-Indicating RP-UPLC Method. Sci. Pharm., 78, 821-834, (2010) https://doi.org/10.3797/scipharm.1004-14

Sharma S, Singh N, Ankalgi AD, Rana A, Ashawat MS. Modern Trends in Analytical Techniques for Method Development and Validation of Pharmaceuticals: A Review, Journal of Drug Delivery and Therapeutics., 11(1-s), 121-130 (2021) https://doi.org/10.22270/jddt.v11i1-s.4515

Ahmed A, Mehfuza UM, Lajporiya M, Nazifa S, Patel S, Khan GJ et al. Development of RP-HPLC Method for Simultaneous Determination of Bilastine and Montelukast by Qbd Approach and Its Validation. Int. J. Life Sci. Pharma. Res., 13(5), 199-220 (2023) https://doi.org/10.22376/ijlpr.2023.13.5.P199-P220

Shah DA, Bhatt KK, Mehta RS, Shankar MB, Baldania SL. RP-HPLC method for the determination of Atorvastatin calcium and Nicotinic acid in combined tablet dosage form. Indian J Pharm Sci., 69, 700–703 (2007) 10.4103/0250-474X.25738

Suchitra D, Satyanarayana B. Development and validation of stability indicating RP-HPLC method for estimation of Ethinyl estradiol and Gestodene in bulk and pharmaceutical dosage form. Int J Pharm Pharm Sci., 13(7), 49-58 (2021) https://dx.doi.org/10.22159/ijpps.2021v13i7.41615

Prathyusha P, Sundararajan R. UV spectrophotometric method for determination of Bilastine in bulk and pharmaceutical formulation. Research Journal of Pharmacy and Technology., 13(2), 933-939 (2020) https://dx.doi.org/10.5958/0974-360X.2020.00176.6

Mounika K, Vamshi Sharathnath K, Jithendar RM, Shanthi Priya DK, Narender B, Manognya K. RP-HPLC method for quantification of aclidinium and formoterol in bulk and pharmaceutical dosage forms. Biochem. Cell. Arch., 25(1), 467-474 (2025) https://dx.doi.org/10.51470/bca.2025.25.1.467

Suchitra D, Satyanarayana B. A Stability indicating Reverse phase HPLC Method Development and Validation for the Estimation of Rucaparib in bulk and pharmaceutical dosage form. Am. J of Anal Chem., 12, 96-107 (2021) https://doi.org/10.4236/ajac.2021.124008

Edward Raju G, Srikanth P, Suneetha Y. Novel Ultra-Performance Liquid Chromatography Method for Concurrent Estimation and Pharmacokinetic Analysis of Favipiravir and Molnupiravir in Rat Plasma. Asian J Pharm Clin Res., 18(2), 90-95 (2025) https://doi.org/10.22159/ajpcr.2025v18i2.53662

Akiful Haque M, Vasudha B, Maneshwar T, Ram Mohan M, Narender B. Development and Validation of UV Spectrophotometric Method for the Determination of Dolutegravir by Using Quality by Design (QbD) Approach. J Adv Sci Res., 12(3) Suppl 1, 113-119 (2021) https://doi.org/10.55218/JASR.s1202112313

Published

2025-12-25

How to Cite

Boddu, R. ., Mandhadi, J. R. ., Boggula, N. ., Vodeti, R. ., & Duddagi, S. . (2025). Development of expeditious RP-HPLC method for simultaneous estimation of bilastine and montelukast in fixed dosage combination. Journal of Applied Pharmaceutical Research, 13(6), 113-119. https://doi.org/10.69857/joapr.v13i6.1447

Issue

Section

Articles